Many sinusitis patients don’t have a lingering infection—they have a chronic inflammatory reaction to fungi. This post reviews a key paper on chronic rhinosinusitis, explains the fungal–eosinophilic model, and explores how intranasal Amphotericin B can help reduce inflammation, improve symptoms, and potentially delay or avoid surgery.
Dr. Andrew Campbell — clinical immunologist, toxicologist, and author of 100+ peer-reviewed studies — joins host Rob Lutz to discuss the under-recognized epidemic of mycotoxin illness. From autism and MS to Alzheimer’s and Crohn’s disease, mycotoxins masquerade as conditions practitioners treat daily. Dr. Campbell outlines his evidence-based six-month protocol —Read
Large observational cohorts, Mendelian-randomization genetics, and post-hoc analyses of phase‑3 trials link low 25(OH)D to higher MS risk and MRI activity. This practical, nontechnical summary for naturopathic and holistic clinicians reviews evidence, sensible target ranges, safe dosing approaches, monitoring, and how to integrate vitamin D into prevention and supportive care.
Findings from a new study on vitamin D and autism shed light on the possible beneficial effects of vitamin D in regulating pro-inflammatory and anti-inflammatory markers, including TNF-α, and IL-37, respectively, as well as alleviating the behavioral symptoms of children with ASD.
This review gives practitioners a practical roadmap to recognize B‑vitamin insufficiency, interpret labs, and choose evidence‑based repletion regimens.
Research published in Progress in Lipid Research clarifies how PS and DHA team up to enhance survival pathways in the brain, shape the brain’s synaptic release, and even influence memory. The study also highlights how diet, alcohol, and targeted supplements are involved and impact brain signaling.
Melatonin is widely known for regulating the sleep–wake cycle, but its clinical potential extends far beyond circadian support. Synthesized primarily by the pineal gland, and to a lesser extent in peripheral tissues, melatonin functions as a potent antioxidant, an anti-inflammatory and immunomodulatory agent, a neuroprotective molecule, and an adjunctive anticancer therapy.
Curcumin shows significant promise as a natural intervention for healthy aging, with particular strength in cognitive enhancement, mood support, and muscle health preservation.
A solid supplement protocol can optimize the body’s natural detoxification processes and expedite a patient’s recovery from mycotoxin illness. Since many patients with mycotoxin illness struggle with neurological consequences, supplements that help support brain health can address common symptoms like brain fog, confusion, memory loss, sleep disruption, anxiety, depression, and mood swings. Supplements may also help repair the immune system, support the body’s cellular function and metabolic processes, and reverse oxidative cellular and tissue damage.
Curcumin appears to be a promising broad‑spectrum protective agent against diverse chemical and natural toxicants in preclinical models. It is generally well tolerated in humans, but poor oral bioavailability, heterogeneous dosing, and a lack of well‑controlled human trials mean it is not yet ready for routine, evidence‑based recommendation as a primary “detox” therapy.
